By Published: Oct 13, 2015 .
Sales of $17.1 Billion Decreased 7.4% Versus 2014 Third QuarterThird-Quarter EPS was $1.20Adjusted 2015 Third-Quarter EPS of $1.49 Decreased 7.5%* Driven by CurrencyContinued Solid Operational Sales Growth Excluding Hepatitis C Impact$10 Billion Share Repurchase Program Announced Today
NEW BRUNSWICK, N.J., Oct. 13, 2015 /PRNewswire/ -- Johnson & Johnson JNJ, -0.77% today announced sales of $17.1 billion for the third quarter of 2015, a decrease of 7.4% as compared to the third quarter of 2014. Operational sales results increased 0.8% and the negative impact of currency was 8.2%. Domestic sales decreased 0.6%. International sales decreased 13.7%, reflecting operational growth of 2.1% and a negative currency impact of 15.8%. Excluding the net impact of acquisitions, divestitures and hepatitis C sales, on an operational basis, worldwide sales increased 5.6%, domestic sales increased 7.7% and international sales increased 3.8%. [*] Earlier today, the Company also announced its Board of Directors has approved the repurchase of up to $10 billion of the company's common stock.
...